Demeetra Hera Acquisition announcement
Hera BioLabs has been acquired by Demeetra.
Demeetra is now focused on advancing Super piggyBac® transposase technology and engineering the CleanCut CHO Platform for next-generation cell line development.
Super piggyBac is exclusively licensed by Demeetra for research, development, and substantially all commercial use.